Aspen Pharmacare Holdings Limited (JSE:APN)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 14,682
-539 (-3.54%)
Aug 11, 2026, 5:04 PM SAST
Aspen Pharmacare Holdings Financials Overview
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 42,592 | 43,363 | 44,706 | 40,709 | 38,606 | 37,766 |
Revenue Growth | -1.78% | -3.00% | 9.82% | 5.45% | 2.22% | 12.20% |
Gross Profit Gross Profit Growth | 18,309 | 19,052 | 19,416 | 18,869 | 18,256 | 17,779 |
Operating Income Operating Income Growth | 6,043 | 6,994 | 8,867 | 8,929 | 8,740 | 8,107 |
Net Income Net Income Growth | -1,999 | -1,083 | 4,404 | 5,228 | 6,488 | 4,806 |
Earnings Per Share EPS Growth | -4.50 | -2.44 | 9.91 | 11.77 | 14.32 | 10.53 |
EPS Growth | - | - | -15.76% | -17.83% | 36.04% | 3.04% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Commercial Pharmaceuticals - Prescription Commercial Pharmaceuticals - Prescription Growth | 12,535 | 12,519 | 11,380 | 10,286 | - | - |
Commercial Pharmaceuticals - OTC Commercial Pharmaceuticals - OTC Growth | 9,988 | 9,812 | 9,706 | 9,388 | - | - |
Commercial Pharmaceuticals - Injectables Commercial Pharmaceuticals - Injectables Growth | 10,232 | 9,885 | 9,484 | 10,796 | - | - |
Manufacturing Manufacturing Growth | 9,837 | 11,147 | 14,136 | 12,190 | 10,948 | 9,892 |
Total Total Growth | 42,592 | 43,363 | 44,706 | 42,660 | 38,606 | 37,766 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 5,620 | 6,409 | 12,337 | 10,912 | 6,183 | 8,555 |
Total Debt Total Debt Growth | 32,943 | 36,120 | 36,455 | 29,282 | 22,247 | 24,906 |
Net Cash (Debt) Net Cash Growth | -27,323 | -29,711 | -24,118 | -18,370 | -16,064 | -16,351 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -61.50 | -66.92 | -54.30 | -41.36 | -35.46 | -35.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,931 | 5,159 | 6,225 | 5,520 | 5,374 | 6,825 |
Capital Expenditures CapEx Growth | -2,507 | -2,576 | -3,117 | -2,230 | -1,963 | -2,045 |
Free Cash Flow Free Cash Flow Growth | 4,424 | 2,583 | 3,108 | 3,290 | 3,411 | 4,780 |
Free Cash Flow Growth | 71.27% | -16.89% | -5.53% | -3.55% | -28.64% | -23.16% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 42.99% | 43.94% | 43.43% | 46.35% | 47.29% | 47.08% |
Operating Margin | 14.19% | 16.13% | 19.83% | 21.93% | 22.64% | 21.47% |
Pretax Margin | -2.61% | -0.28% | 12.78% | 16.10% | 21.07% | 15.86% |
Profit Margin | -4.69% | -2.50% | 9.85% | 12.84% | 16.81% | 12.73% |
FCF Margin | 10.39% | 5.96% | 6.95% | 8.08% | 8.83% | 12.66% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.110 | 2.110 | 3.590 | 3.420 | 3.260 | 2.620 |
Dividend Per Share Growth | -41.23% | -41.23% | 4.97% | 4.91% | 24.43% | - |
Dividend Yield | 1.39% | 1.80% | 1.60% | 1.98% | 2.55% | 1.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | 23.57 | 15.63 | 9.56 | 15.36 |
Forward PE | 16.95 | 9.58 | 12.68 | 10.44 | 7.34 | 11.63 |
P/FCF Ratio | 14.74 | 20.55 | 33.40 | 24.83 | 18.19 | 15.45 |
PS Ratio | 1.53 | 1.22 | 2.32 | 2.01 | 1.61 | 1.96 |